Amazon Eczema Cream Recall: Hidden Life-Threatening Bacteria!

A popular eczema cream sold on Amazon and in grocery stores nationwide has been recalled after federal regulators confirmed bacterial contamination that could trigger life-threatening infections — and the product may still be in your medicine cabinet.

Story Snapshot

Pharmacal has recalled one lot of MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream after the U.S. Food and Drug Administration (FDA) confirmed contamination with Staphylococcus aureus bacteria.
The affected product, lot 1024088 with an expiration date of November 2026, was distributed nationwide through Amazon, wholesale channels, and H-E-B grocery stores.
The FDA warns that use of the contaminated cream could cause infections ranging from localized skin issues to potentially fatal conditions like sepsis and septic shock, particularly in people with weakened immune systems.
No adverse events or consumer injuries have been reported as of the recall announcement, but the FDA acted on contamination findings alone — consistent with standard precautionary recall practice.

What Was Recalled and Why It Matters

On May 8, 2026, Pharmacal of Jackson, Wisconsin, announced a voluntary recall of one specific lot of MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream. The recall was conducted with full knowledge of the FDA, which confirmed the product was contaminated with Staphylococcus aureus — the bacteria responsible for staph infections. The affected lot number is 1024088, with a UPC of 012277051067 and an expiration date of November 2026.

Eczema sufferers already deal with inflamed, broken, or sensitive skin — exactly the condition that makes bacterial exposure most dangerous. Applying a contaminated topical cream directly to compromised skin creates a direct pathway for infection, which is why regulators treat microbial contamination in these products as a serious public health concern even before any injuries are reported.

The FDA’s Risk Warning: From Skin Infections to Septic Shock

The FDA’s risk statement tied to this recall is stark. According to the agency, use of the contaminated cream “could result in a range of infections from localized to severe or life-threatening adverse events.” People with weakened immune systems or already-damaged skin face the highest danger, with named risks including skin and skin structure infections, infective endocarditis, bone and joint infections, bloodstream infections, and life-threatening conditions like sepsis and septic shock.

The FDA’s decision to act without a single reported injury on record reflects how the agency is supposed to work — identifying risk before harm occurs rather than waiting for body counts. Precautionary recalls of topical products contaminated with bacteria are common precisely because the exposure pathway is direct and the vulnerable population, in this case eczema patients, is clearly identifiable. That is responsible regulation, and it is working as intended.

Where the Product Was Sold and What to Do Now

The recalled lot reached consumers through a broad distribution network. According to the FDA notice, the product was shipped nationwide to wholesale distributors, retail grocery locations including H-E-B, and internet distributors including Amazon. If you purchased MG217 Multi-Symptom Treatment Cream recently, check the lot number printed on the packaging. Lot 1024088, expiring November 2026, is the affected batch.

MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream by Pharmacal: Recall – Due to Microbial Contamination https://t.co/FGulpFosCO pic.twitter.com/wkW1qA6oTv

— US FDA MedWatch (@FDAMedWatch) May 13, 2026

Consumers who have the recalled product should stop using it immediately and contact Pharmacal for return or refund instructions. Anyone who has already used the cream and develops signs of skin infection, fever, or unusual symptoms should contact a healthcare provider promptly. The FDA and Pharmacal have both stated that no adverse events linked to this lot had been reported at the time of the recall announcement, but that does not mean the risk is zero — it means the recall caught the problem before documented harm occurred. Check the FDA’s website for the most current recall status and any updates from the company.